Drug Profile
Research programme: TRAF2 and NCK-Interacting kinase inhibitors - Carna Biosciences
Alternative Names: N5355; NC-1Latest Information Update: 27 Sep 2023
Price :
$50
*
At a glance
- Originator Carna Biosciences
- Class Thiazoles
- Mechanism of Action Germinal centre kinase inhibitors; Wnt signalling pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Sep 2023 Discontinued - Preclinical for Cancer in Japan (PO)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Cancer in Japan (PO)
- 29 Nov 2016 Preclinical trials in Cancer in Japan before November 2016 (PO)